SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Shares Issued
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Shares Issued of 1.00 million shares as of 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-09-24
- 2026-06-30: Common Stock, Shares, Issued 1.00M shares.
- 2026-03-31: Common Stock, Shares, Issued 5.55M shares.
- 2025-12-31: Common Stock, Shares, Issued 202.36K shares; Common Stock, Shares, Issued as first filed 2.02M shares.
- 2025-09-30: Common Stock, Shares, Issued 1.24M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 1.00M shares 10-Q · filed 2026-09-24 | |
| 2026-03-31 | 5.55M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 202.36K shares 10-Q · filed 2026-09-24 | 2.02M shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 1.24M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 1.07M shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 6.38M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 163.09K shares 10-K · filed 2026-03-31 | 4.08M shares 10-K · filed 2025-02-26 |
| 2024-09-30 | 2.95M shares 10-Q · filed 2024-11-13 | |
| 2024-08-13 | 2.11M shares 10-Q/A · filed 2024-09-04 | |
| 2024-06-30 | 2.11M shares 10-Q · filed 2024-09-04 | |
| 2024-03-31 | 2.10M shares 10-Q/A · filed 2024-09-04 | 16.82M shares 10-Q · filed 2024-05-13 |
| 2023-12-31 | 2.01M shares 10-K · filed 2025-02-26 | 16.07M shares 10-K · filed 2024-03-21 |
| 2023-09-30 | 16.00M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 15.48M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 13.65M shares 10-Q · filed 2023-05-25 | |
| 2022-12-31 | 1.70M shares 10-K/A · filed 2024-09-04 | 13.60M shares 10-K · filed 2023-03-15 |
| 2022-09-30 | 13.59M shares 10-Q · filed 2022-11-14 | |
| 2021-12-31 | 9.31M shares 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |